GSK joins China trade push as UK trumpets health care deals
GlaxoSmithKline's chief executive is joining a new panel to promote trade between Britain and China, just over a year after the drugmaker was handed a record fine of nearly US$500 million for bribing Chinese doctors.
The group has since been rebuilding its position in China.
The move came as Britain announced the signing of more than £2 billion of health care trade deals between Chinese and British companies, universities and organisations during President Xi Jinping's visit to Britain.
In addition to GSK's Andrew Witty, the China-Britain Business Council said on Wednesday its new 30-strong advisory council would also include WPP chief executive Martin Sorrell, Jaguar Land Rover boss Ralf Speth, Rio Tinto chief executive Sam Walsh and HSBC chairman Douglas Flint.